Connect With the Companies Defining the Future of Cell & Gene Therapies
As in vivo engineering becomes the fastest‑growing focus in cell and gene therapy, developers are seeking partners who can help them scale manufacturing, strengthen CMC readiness, advance delivery technologies, accelerate IND timelines, and support global clinical expansion. With rising momentum in non‑viral vector manufacturing, targeted LNP development, analytical characterization, and Asia‑based IIT support, the need for experienced CDMOs, CROs, and technology providers has never been greater.
The 5th In Vivo Cell Engineering & Gene Editing Summit is your opportunity to position your organization at the center of this movement. Across three days of high‑engagement content and structured networking, you will meet biotechs and pharma teams actively evaluating collaborators to help them progress delivery systems, de‑risk preclinical programs, scale production, and navigate a rapidly evolving regulatory landscape.
Partnering this year signals that your services, expertise, and capabilities align with where the field is heading and ensures your brand is front‑of‑mind as developers prepare the next wave of in vivo programs.
What to Expect?
Meet High‑Intent Prospects
Engage face‑to‑face with R&D, translational, CMC, and BD leaders seeking partners for manufacturing, delivery optimization, analytical development, safety testing, and IND‑enabling support.
Strengthen Your Position in a Competitive Market
Place your brand directly in front of companies preparing the next wave of editing, delivery, and early clinical programs, ensuring your organization is seen as ready to support this shift.
Demonstrate Your Expertise
Showcase your capabilities through speaking opportunities, panel participation, or a tailored exhibition presence designed to highlight your unique strengths in supporting in vivo development.
Gain Real‑Time Market Intelligence
Hear directly from innovators and decision makers to understand their priorities, technical challenges, outsourcing needs, and long‑term partnership requirements as in vivo therapies advance.
Key Interest Areas
Our attendees are actively seeking partners with capabilities across the in vivo development ecosystem, including but not limited to the areas below.
- Global Contract Research Organizations
- Preclinical Model Providers
- Viral Vector CDMO & Technology Providers
- Non‑Viral Vector CDMO & Technology Providers
- Other Solutions for In Vivo Drug Developers
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Available Inventory
We offer a range of partnership opportunities designed to elevate your visibility, demonstrate your expertise, and position your organization as a critical partner in the fast-growing in vivo cell engineering and gene editing space.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Jake Bennett
Partnerships Director
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.